DrugRisk Update: FDA Investigating Pre-Cancerous Risk of Januvia

Share Article

DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

januvia lawsuit
Anyone affected by cancer after taking Januvia is encouraged to speak with a lawyer about their legal options.

The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those taking the medications Januvia or Janumet. The FDA is investigating whether these drugs are related to cancer after a study found pre-cancerous cell growth in patients who had died*.

DrugRisk was created to improve patient safety by providing the latest warnings, recalls, studies and legal news to those taking popular prescription drugs. Visitors can see if others are experiencing similar side effects and decide if they need legal advice.

The resource center contains information on Januvia and Janumet, which are pill-form diabetes medications prescribed to help those with type-2 diabetes control blood sugar. The drugs were two of the best-selling for Merck in recent years, with sales of $4 billion and $1.7 billion respectively last year**.

DrugRisk contains prior studies suggesting Januvia and Janumet may be linked to cancer. A 2011 study from UCLA indicated the drug could increase the risk of pancreatic cancer by 172% and thyroid cancer by 48%***. The Journal for the American Medical Association also recently warned Januvia could double the risk of pancreatitis, a major risk factor for pancreatic cancer****.

Due to the rising number of patients filing a Januvia lawsuit alleging cancer, lawyers have requested that cases be consolidated to a special federal multi-district court in California. (In Re: Incretins Products Liability, Sales and Marketing Litigation, MDL 2452, United States Judicial Panel on Multidistrict Litigation).

Now, DrugRisk has learned that the FDA is also investigating the risk of Januvia and Janumet cancer after receiving reports that some patients who died showed signs of early pancreatic cancer cells*.

Anyone affected by cancer after taking Januvia is encouraged to speak with a lawyer about their legal options. However, due to the specialized nature of federal drug injury cases, DrugRisk only recommends lawyers who have already handled Januvia lawsuits.

For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*FDA, 3/14/13; http://www.fda.gov/Drugs/DrugSafety/ucm343187.htm
**Bloomberg, 2/25/13; bloomberg.com/news/2013-02-25/merck-bristol-diabetes-drugs-linked-to-pancreatitis-risk.html
***Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
****JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Patient Advocate
DrugRisk
888-415-1859
Email >
Visit website